Search Results for "Pharmaceutical Company Organization Chart"

14:04 EDT 24th October 2014 | BioPortfolio

Matching Channels

Contract Research Organization news

A contract research organization, also called a clinical research organization, (CRO) is a service organization that provides support to the pharmaceutical and biotechnology industries in the form o...

Visual acuity

Visual acuity (VA) is acuteness or clearness of vision, which is dependent on the sharpness of the retinal focus within the eye and the sensitivity of the interpretative faculty of the brain. Visu...

MediciGlobal is a specialty patient recruitment-retention organization serving the clinical trials industry

MediciGlobal is a specialty patient recruitment-retention organization serving the clinical trials industry. For more than two decades, the company has led the industry in developing innovative p...

Orphan Diseases

The European Organization for Rare Diseases considers orphan diseases to be those that are rare (occur in 1 in 1500 to 1 in 2500 patients, according to US Rare Disease Act 2002 and European Commissi...

Orphan Drugs

An orphan drug is a pharmaceutical product aimed at rare diseases or disorders. The development of orphan drugs has been financially incentivised through US law via the ‘Orphan Drug Act o...

Matching News

Chart Links, LLC - Company Capsule

Recently added to the BioPortfolio report store, Chart Links, LLC - Company Capsule is a new report from ICD Research published on 2011-11-30. This 8-page report is available from $75. ICD Research...

Bad timing for good news? New chart shows FDA is flying through its drug reviews

Good news (or is it?): The average U.S. Food and Drug Administration drug review time is at its lowest point this century. A handy chart from the California Healthcare Institute...

Cardio3 BioSciences Receives Authorization to Enroll Patients in Sweden in its Phase III Clinical Trial CHART-1

CHART-1 trial represents the world's first Phase III trial in regenerative medicine for a pre-programmed cellular therapy targeting heart failure To date, ten countries have granted authorization ...

Cardio3 Biosciences receives approval for the continuation of its chart-1 Phase iii clinical trial from the DSMB

Cardio3 BioSciences SA announces it has received the recommendation of the Data Safety and Monitoring Board (DSMB) to continue the CHART-1 clinical trial according to the original protocol...

C3BS Enrolls Patients in Switzerland in its Phase 3 Clinical Trial Chart-1

Cardio3 BioSciences (C3BS), a leader in the discovery and development of regenerative, protective and reconstructive therapies, announced it has received authorization from Swissmedic, the Swiss agenc...

Political Cartoon: 'Pie Chart?'

Kaiser Health News provides a fresh take on health policy developments with "Pie Chart?" by Lee Judge. Meanwhile, here's today's haiku: SURVEYING THE GOLDEN STATE California picks the l...

Dividends, Joint Ventures, Opening of Fuel Stations, Scheduled Conferences and Earnings Results - Analyst Notes on Waste Management, Tenaris, Chart Industries, CleanHarbors and RTI

NEW YORK, May 28, 2014 /PRNewswire/ -- Today, Analysts Review released its analysts' notes regarding Waste Management, Inc. (NYSE: WM), Tenaris SA (NYSE: TS), Chart Industries Inc. (NASDAQ: GTLS),...

Political Cartoon: 'Out Of Your Depth Chart?'

Kaiser Health News provides a fresh take on health policy developments with "Out Of Your Depth Chart?" by Nick Anderson. And here's today's health policy haiku: GET THE SHOT Ebola's a s...

Matching PubMed Articles

A new risk-adjusted Bernoulli cumulative sum chart for monitoring binary health data.

To monitor a health event in patients with a specific risk of developing the event, a risk-adjusted cumulative sum chart is needed. The risk-adjusted cumulative sum chart proposed in the literature ha...

Individual Differences in Subjective Organization and Verbal Learning in Old Age.

Background/Study Context: Previous research has shown an increase of subjective organization of stimuli and of recall performance across learning trials. However, up to date, it has not been examined ...

Reason for hospital admission: a pilot study comparing patient statements with chart reports.

Providers and patients bring different understandings of health and disease to their encounters in the hospital setting. The literature to date only infrequently addresses patient and provider concord...

Organizing MHC Class II Presentation.

Major histocompatibility complex (MHC) class II molecules are ligands for CD4(+) T cells and are critical for initiating the adaptive immune response. This review is focused on what is currently known...

Rich-club organization of the newborn human brain.

Combining diffusion magnetic resonance imaging and network analysis in the adult human brain has identified a set of highly connected cortical hubs that form a "rich club"-a high-cost, high-capacity b...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement